Clinical Trial Update: Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin) [Phase 3]

View source ↗

Summary

A Phase 3 confirmatory trial evaluating MT-2412 as an add-on to Teneligliptin in Japanese patients with Type 2 Diabetes Mellitus has completed, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MT-2412
• Teneligliptin (Teneligliptin)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2018-08-16